Cabot (NYSE:CBT) Stock Rating Upgraded by StockNews.com

Cabot (NYSE:CBT) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday.

A number of other analysts have also weighed in on CBT. JPMorgan Chase & Co. cut their price objective on Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research report on Friday, February 21st. UBS Group cut their price target on Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a report on Monday, April 7th. Finally, Mizuho decreased their price objective on Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $93.25.

Cabot Stock Performance

Shares of Cabot stock opened at $78.41 on Thursday. The stock has a market capitalization of $4.25 billion, a price-to-earnings ratio of 10.41, a price-to-earnings-growth ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. The business has a 50-day moving average of $83.02 and a 200 day moving average of $95.35. Cabot has a 12 month low of $73.63 and a 12 month high of $117.46.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, sell-side analysts forecast that Cabot will post 7.57 earnings per share for the current year.

Institutional Trading of Cabot

Institutional investors have recently bought and sold shares of the business. R Squared Ltd acquired a new stake in shares of Cabot during the 4th quarter worth about $26,000. EverSource Wealth Advisors LLC increased its stake in Cabot by 37.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock valued at $74,000 after purchasing an additional 219 shares during the last quarter. Curat Global LLC acquired a new stake in Cabot during the first quarter worth approximately $83,000. GAMMA Investing LLC lifted its position in shares of Cabot by 10.7% during the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock worth $123,000 after buying an additional 130 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Cabot by 1,346.4% in the 1st quarter. Farther Finance Advisors LLC now owns 1,620 shares of the specialty chemicals company’s stock valued at $136,000 after buying an additional 1,508 shares in the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.